SITC 2017

November 8-12 | Gaylord National Resort & Convention Center, National Harbor, MD

Visualize a new path forward

Empowering the immune system to recognize and eliminate tumors has tremendous potential to change the way cancer is treated and eventually cured. At Fluidigm, we enable comprehensive cellular profiling of the immune system and the tumor microenvironment with proven mass cytometry and microfluidics technologies.

Whether you seek to target new biomarkers and pathways or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Fluidigm can help you identify new insights to reach your next research breakthrough.

Join us for a Dinner Seminar

Comprehensive Characterization of the Tumor Microenvironment with Imaging Mass Cytometry

Please join us for an evening of cocktails, dinner and presentations by leading researchers who are using Imaging Mass Cytometry™ to gain a comprehensive view of complex cellular phenotypes and their relationships in the context of the tumor microenvironment.

When:	Thursday, November 9, 2017
	6:00‒7:00 pm Cocktails 7:00–10:00 pm Dinner and presentations
Where:	The Sunset Room 137 National Plaza #200 National Harbor, Maryland

Presenters

	Analysis of tissue ecosystems in health and disease by Imaging Mass Cytometry Bernd Bodenmiller, PhD—University of Zurich
	Understanding the immune composition of human lung cancer using Imaging Mass Cytometry Kurt Schalper, MD, PhD—Yale University

See Product Presentations

Visit Fluidigm at Booth 325 and hear about the Hyperion™ Imaging System, an exciting new product that is transforming tumor imaging.

Exhibition Dates & Hours
Friday, November 10: 12:30–7:45 pm
Saturday, November 11: 12:30–8:00 pm

Hyperion Imaging System

Comprehensively interrogate complex cellular phenotypes and their interrelationships in the context of the tumor microenvironment with Imaging Mass Cytometry.

Helios™, a CyTOF^® system

Deeply profile immune and tumor cell populations for phenotype and function, all in a single tube.

Biomark HD

Reveal the molecular signatures of tumor immune response using the Advanta™ Immuno-Oncology Gene Expression Assay on the Biomark™ HD.

Visit Posters and Presentations Featuring Fluidigm Technology

Presentations: Thursday, November 9

Time	Title	Presenter, Institution	Location
10:35‒11:00 am	Myeloid cells in lung tumors using CyTOF^®	Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai	Workshop on Single Cell Techniques/ Session II, Tumor Immune Microenvironment
11:00‒11:25 am	Computational methods for analyzing single cells in the tumor microenvironment	Dana Pe’er, PhD Sloan Kettering Cancer Center

Posters: Friday, November 10 and Saturday, November 11

Poster	Title	Presenter, Institution	Location
P80	Testing systems immune monitoring by mass cytometry for clinical research	Caroline Roe, BS Vanderbilt University	Biomarkers and Immune Monitoring
P173	Mass cytometry based immunophenotyping of tumor-reactive T cells in human cancer reveals subpopulations with coordinate inhibitory molecule expression	Monika Aleksandra Eiva, BS University of Pennsylvania	Cellular Therapy Approaches
P379	Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade	Spencer Wei, PhD The University of Texas MD Anderson Cancer Center	Mechanisms of Efficacy or Toxicity
P489	Studying the cellular heterogeneity and spatial arrangement of immune cells in FFPE sections of Hodgkin Lymphoma and normal lymph node using a highly multiplexed Imaging Mass Cytometry	Mohan Singh, PhD University of Southern California	Tumor Microenvironment (Mechanisms and Therapies)

Social Media

Can't make it to all of the sessions? Follow @fluidigm with #SITC2017 and like us on Facebook for scientific and event updates.

For Research Use Only. Not for use in diagnostic procedures.